EUVIMEDEUVIMED entdecken
Crossref

Long-Term Outcomes of Autologous Transplantation in Multiple Myeloma: Significant Survival Benefit of Novel Drugs in Post-Transplantation Relapse

Marta Krejci, Vlastimil Scudla, Elen Tothova, Miroslava Schutzova, Vladimir Koza, Zdenek Adam, Andrea Krivanova, Ludek Pour, Tomas Buchler, Viera Sandecka, Dana Kralova, Lenka Zahradova und 3 weitere

Clinical Lymphoma and Myeloma · 2009-12 · 9 (6) · 436-442

DOI: 10.3816/clm.2009.n.086 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Lymphoma and Myeloma, 2009-12. Verfasst von Marta Krejci und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine - Hematooncology, Masaryk University Hospital, Jihlavska 20, 625 00 Brno, Czech Republic. mkrejci@fnbrno.cz. Hauptthemen laut MEDLINE: Hematopoietic Stem Cell Transplantation. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 25 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hematopoietic Stem Cell TransplantationAdultAgedBoronic AcidsBortezomibDisease ProgressionHumansMiddle AgedMultiple MyelomaPyrazinesRecurrenceThalidomideTransplantation, AutologousTreatment Outcome

Substanzen

Boronic AcidsPyrazinesThalidomideBortezomib

Autor:innen und Institutionen

  • Department of Internal Medicine - Hematooncology, Masaryk University Hospital, Jihlavska 20, 625 00 Brno, Czech Republic. mkrejci@fnbrno.cz

Zitieren

APA

Krejci, M., Scudla, V., Tothova, E., Schutzova, M., Koza, V., Adam, Z., Krivanova, A., Pour, L., Buchler, T., Sandecka, V., Kralova, D., Zahradova, L., Vorlicek, J., Mayer, J., & Hajek, R. (2009). Long-Term Outcomes of Autologous Transplantation in Multiple Myeloma: Significant Survival Benefit of Novel Drugs in Post-Transplantation Relapse. Clinical Lymphoma and Myeloma, 9(6), 436-442. https://doi.org/10.3816/clm.2009.n.086

Vancouver

Krejci M, Scudla V, Tothova E, Schutzova M, Koza V, Adam Z, et al. Long-Term Outcomes of Autologous Transplantation in Multiple Myeloma: Significant Survival Benefit of Novel Drugs in Post-Transplantation Relapse. Clinical Lymphoma and Myeloma. 2009;9(6):436-442. doi:10.3816/clm.2009.n.086

BibTeX
@article{Krejci2009,
  author = {Krejci, Marta and Scudla, Vlastimil and Tothova, Elen and Schutzova, Miroslava and Koza, Vladimir and Adam, Zdenek and Krivanova, Andrea and Pour, Ludek and Buchler, Tomas and Sandecka, Viera and Kralova, Dana and Zahradova, Lenka and Vorlicek, Jiri and Mayer, Jiri and Hajek, Roman},
  title = {Long-Term Outcomes of Autologous Transplantation in Multiple Myeloma: Significant Survival Benefit of Novel Drugs in Post-Transplantation Relapse},
  journal = {Clinical Lymphoma and Myeloma},
  year = {2009},
  volume = {9},
  number = {6},
  pages = {436--442},
  doi = {10.3816/clm.2009.n.086}
}
Kostenlos starten →